SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (29916)1/7/2000 7:26:00 AM
From: Henry Niman  Respond to of 32384
 
LGND hasn't said anything about Japan, but that has been a popular area for deals with San Diego Biotechs in the past, so I'm sure that LGND knows who to call.

As Walter said, LGND is starting hit on all cylinders, and a continued flow of good news would not surprise me.



To: Torben Noerup Nielsen who wrote (29916)1/7/2000 9:12:00 AM
From: celeryroot.com  Read Replies (2) | Respond to of 32384
 
"What intrigues me is that I
believe EU registration is essentially a one step process now and thus they're getting multiple entities to kick in
to pay for the same thing."

I think your right abt one step but I believe you still have to deal from country to country on pricing and labeling


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News